Source: Eur Respir J 2016; 48: 1818



Rating:

Share or cite this content

Citations should be made in the following way:
Nicholas T. Vozoris, Denis E. O'Donnell, Sudeep S. Gill. Opioids and adverse outcomes in elderly chronic obstructive pulmonary disease patients. Eur Respir J 2016; 48: 1818

Member's Comments

No comment yet.

Related content which might interest you: Roflumilast in severely ill patients with chronic obstructive pulmonary disease with frequent exacerbations: real-life outcomes Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD Year: 2020 Cardiovascular comorbidities in chronic obstructive pulmonary disease patients Source: International Congress 2017 – COPD biomarkers Year: 2017 Hyperglycemia is associated with poor outcomes in patients with acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Cardiovascular comorbidity and mortality in patients with chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD epidemiology Year: 2012 Frequency of adverse consequences after spirography in patients with chronic obstructive pulmonary disease and concomitant ischemic heart disease Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Psychological outcomes from pulmonary rehabilitation in patients with chronic obstructive lung disease Source: Annual Congress 2010 - The psychological impact and educational issues of chronic lung disease: could we do more? Year: 2010 Cardiac biomarkers and outcome in patients with acute exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD exacerbation Year: 2012 Readmission predictors in patients with chronic obstructive pulmonary disease hospitalized for an exacerbation Source: Annual Congress 2011 - Exacerbations and severe chronic respiratory disease: oxygen, rehabilitation, admission to hospital and palliative care Year: 2011 Real-life experience of older patients requiring NIV for exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2009 - New trends in noninvasive ventilation for acute respiratory failure Year: 2009 Hospitalization burden in chronic obstructive pulmonary disease patients after pulmonary rehabilitation Source: Annual Congress 2003 - Outcome of integrated care on burden of chronic respiratory failure Year: 2003 A study of hematologic disorders in patients with chronic obstructive pulmonary disease Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease Year: 2020 Mortality in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 210s Year: 2001 Hyperglycaemia and its association with outcomes in people admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 332s Year: 2006 Proactive integrated care improves quality of life in patients with COPD Source: Eur Respir J 2009; 33: 1031-1038 Year: 2009 The efficacy and side-effects of varenicline in patients with mild to moderate chronic obstructive pulmonary diseases Source: Annual Congress 2010 - Passive smoking Year: 2010 Acute exacerbations of chronic obstructive pulmonary disease: Impact of cardiovascular co-morbidities Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD Year: 2010 Bronchiectasis impact outcomes in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008 Factors affecting in-hospital mortality in patients with chronic obstructive pulmonary disease exacerbation Source: Annual Congress 2013 –The latest insights in chronic care Year: 2013 Can we predict the outcomes of treatment of patients with severe exacerbation of chronic obstructive pulmonary disease (COPD)? Source: Eur Respir J 2001; 18: Suppl. 33, 241s Year: 2001 Doxycycline for exacerbations of chronic obstructive pulmonary disease in outpatients: who benefits? Source: ERJ Open Res, 6 (2) 00099-2020; 10.1183/23120541.00099-2020 Year: 2020